Print-friendly View
TB Learning Library
| Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda | |
Attached file: |
(English, 87.8 kb)
Scaling Up Programmatic Management of Drug-Resistant Tuberculosis.pdf
|
Author(s): | Frank G. J. Cobelens*, Einar Heldal, Michael E. Kimerling, Carole D. Mitnick, Laura J. Podewils, Rajeswari Ramachandran, Hans L. Rieder, Karin Weyer, Matteo Zignol |
Description: | Publication from the Stop TB Partnership argues that a great deal of research remains to be done in order to make such a scale-up possible. In the five page article, the Stop TB Partnership Research Sub-Group of the Working Group on MDR-TB lays out a research agenda for five key areas: laboratory support, MDR-TB treatment strategies, programmatically relevant research, epidemiology of MDR-TB, and management of contacts of MDR-TB cases. The report includes specific research priorities, as w...more |
Document type: | Monographs, Reports, and Book Chapters |
Language: | English |
Original language of document: | English |
Primary area(s) of focus: | DOTS-Plus & MDR-TB |
Secondary areas of focus: | DOTS expansion, TB-HIV, TB Vaccines, TB Diagnostics, TB Drugs, Laboratory |
Bibliographic Citation: | Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda Cobelens FGJ, Heldal E, Kimerling ME, Mitnick CD, Podewils LJ, et al. PLoS Medicine Vol. 5, No. 7, e150 doi:10.1371/journal.pmed.0050150 |
Material written specifically for patients: | No |
Date of entry: | August 5, 2008 |
Pages: | 6 |
Overall user rating: | Not yet reviewed |
| Note on Rating Scale - The scale is 1 to 5 with 1 being the least useful/quality and 5 being the best. | |